Methods and compositions for modulating alpha adrenergic receptor activity

Details for Australian Patent Application No. 2001253384 (hide)

Owner Allergan, Inc.

Inventors Fang, Wenkui Ken; Garst, Michael E.; Chow, Ken; Gil, Daniel W; Wheeler, Larry A.

Agent Davies Collison Cave

Pub. Number AU-B-2001253384

PCT Pub. Number WO01/78703

Priority 09548410 13.04.00 US

Filing date 11 April 2001

Wipo publication date 30 October 2001

Acceptance publication date 2 February 2006

International Classifications

A61K 31/00 (2006.01)

Event Publications

2 February 2006 Application Accepted

  Published as AU-B-2001253384

1 June 2006 Standard Patent Sealed

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253385

2001253383-Methods and compositions for modulating alpha adrenergic receptor activity